3,443 views
Here are a list of drugs approved by the U.S. Food and Drug Administration Bureau, included 7 kinds of drugs:
Multi-class Combination Products
| Brand Name |
Generic Names |
Manufacturer Name |
Approval Date |
Time to Approval |
| Atripla |
efavirenz, emtricitabine and tenofovir disoproxil fumarate |
Bristol-Myers Squibb and Gilead Sciences |
12-July-06 |
2.5 months |
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
| Brand Name |
Generic Name(s) |
Manufacturer Name |
Approval Date |
Time to Approval |
| Combivir |
lamivudine and zidovudine |
GlaxoSmithKline |
27-Sep-97 |
3.9 months |
| Emtriva |
emtricitabine, FTC |
Gilead Sciences |
02-Jul-03 |
10 months |
| Epivir |
lamivudine, 3TC |
GlaxoSmithKline |
17-Nov-95 |
4.4 months |
| Epzicom |
abacavir and lamivudine |
GlaxoSmithKline |
02-Aug-04 |
10 months |
| Hivid |
zalcitabine, dideoxycytidine, ddC |
Hoffmann-La Roche |
19-Jun-92 |
7.6 months |
| Retrovir |
zidovudine, azidothymidine, AZT, ZDV |
GlaxoSmithKline |
19-Mar-87 |
3.5 months |
| Trizivir |
abacavir, zidovudine, and lamivudine |
GlaxoSmithKline |
14-Nov-00 |
10.9 months |
| Truvada |
tenofovir disoproxil fumarate and emtricitabine |
Gilead Sciences, Inc. |
02-Aug-04 |
5 months |
| Videx EC |
enteric coated didanosine, ddI EC |
Bristol Myers-Squibb |
31-Oct-00 |
9 months |
| Videx |
didanosine, dideoxyinosine, ddI |
Bristol Myers-Squibb |
9-Oct-91 |
6 months |
| Viread |
tenofovir disoproxil fumarate, TDF |
Gilead |
26-Oct-01 |
5.9 months |
| Zerit |
stavudine, d4T |
Bristol Myers-Squibb |
24-Jun-94 |
5.9 months |
| Ziagen |
abacavir sulfate, ABC |
GlaxoSmithKline |
17-Dec-98 |
5.8 months |
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
| Brand Name |
Generic Name |
Manufacturer Name |
Approval Date |
Time to Approval |
| Intelence |
etravirine |
Tibotec Therapeutics |
18-Jan-08 |
6 months |
| Rescriptor |
delavirdine, DLV |
Pfizer |
4-Apr-97 |
8.7 months |
| Sustiva |
efavirenz, EFV |
Bristol Myers-Squibb |
17-Sep-98 |
3.2 months |
| Viramune |
nevirapine, NVP |
Boehringer Ingelheim |
21-Jun-96 |
3.9 months |
Protease Inhibitors (PIs)
| Brand Name |
Generic Name(s) |
Manufacturer Name |
Approval Date |
Time to Approval |
| Agenerase |
amprenavir, APV |
GlaxoSmithKline |
15-Apr-99 |
6 months |
| Aptivus |
tipranavir, TPV |
Boehringer Ingelheim |
22-Jun-05 |
6 months |
| Crixivan |
indinavir, IDV, |
Merck |
13-Mar-96 |
1.4 months |
| Fortovase |
saquinavir (no longer marketed) |
Hoffmann-La Roche |
7-Nov-97 |
5.9 months |
| Invirase |
saquinavir mesylate, SQV |
Hoffmann-La Roche |
6-Dec-95 |
3.2 months |
| Kaletra |
lopinavir and ritonavir, LPV/RTV |
Abbott Laboratories |
15-Sep-00 |
3.5 months |
| Lexiva |
Fosamprenavir Calcium, FOS-APV |
GlaxoSmithKline |
20-Oct-03 |
10 months |
| Norvir |
ritonavir, RTV |
Abbott Laboratories |
1-Mar-96 |
2.3 months |
| Prezista |
darunavir |
Tibotec, Inc. |
23-Jun-06 |
6 months |
| Reyataz |
atazanavir sulfate, ATV |
Bristol-Myers Squibb |
20-Jun-03 |
6 months |
| Viracept |
nelfinavir mesylate, NFV |
Agouron Pharmaceuticals |
14-Mar-97 |
2.6 months |
Fusion Inhibitors
| Brand Name |
Generic Name |
Manufacturer Name |
Approval Date |
Time to Approval |
| Fuzeon |
enfuvirtide, T-20 |
Hoffmann-La Roche & Trimeris |
13-Mar-03 |
6 months |
Entry Inhibitors - CCR5 co-receptor antagonist
| Brand Name |
Generic Names |
Manufacturer Name |
Approval Date |
Time to Approval |
| Selzentry |
maraviroc |
Pfizer |
06-August-07 |
8 months |
HIV integrase strand transfer inhibitors
| Brand Name |
Generic Names |
Manufacturer Name |
Approval Date |
Time to Approval |
| Isentress |
raltegravir |
Merck & Co., Inc. |
12–Oct-07 |
6 months |
If you liked the article link to it!
Related Posts
